Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium.
about
Gastrin: a distinct fate of neurogenin3 positive progenitor cells in the embryonic pancreasA key role for E-cadherin in intestinal homeostasis and Paneth cell maturationSelective gene expression by rat gastric corpus epitheliumBasic helix-loop-helix transcription factors and enteroendocrine cell differentiationInsulin-secreting β cells require a post-genomic conceptStomach development, stem cells and diseaseOrganoid Models of Human Gastrointestinal Development and DiseaseLineage selection and plasticity in the intestinal cryptEpigenetic silencing of Notch signaling in gastrointestinal cancersGenerating human intestinal tissues from pluripotent stem cells to study development and diseaseArx is required for normal enteroendocrine cell development in mice and humansDirect regulation of intestinal fate by NotchDelta1 expression, cell cycle exit, and commitment to a specific secretory fate coincide within a few hours in the mouse intestinal stem cell systemRequirement of the tissue-restricted homeodomain transcription factor Nkx6.3 in differentiation of gastrin-producing G cells in the stomach antrumGenetic identification of a novel NeuroD1 function in the early differentiation of islet alpha, PP and epsilon cellsGfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiationThe zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cellsTargeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation.Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development.NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colonProtein therapy using MafA fused to a polyarginine transduction domain attenuates glucose levels of streptozotocin‑induced diabetic mice.Notch: architect, landscaper, and guardian of the intestine.Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomesPdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells.Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival.Transdifferentiation: a cell and molecular reprogramming process.Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fateGATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature miceIntestinal development and differentiation.The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in miceComplex regulation controls Neurogenin3 proteolysis.Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP alleleDe novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis.Historical perspective: beginnings of the beta-cell: current perspectives in beta-cell developmentAmyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease.A CRM1-mediated nuclear export signal is essential for cytoplasmic localization of neurogenin 3 in neurons.FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.A stem cell marker-expressing subset of enteroendocrine cells resides at the crypt base in the small intestineA mouse model for monitoring islet cell genesis and developing therapies for diabetes
P2860
Q21089759-E36739B2-5762-4CD4-9ED4-97E8C0ADCA09Q21136045-A294DB75-74DA-4F8E-864E-0079DFE2C4DEQ24629261-A29DDF55-5023-4FA7-A84F-DF3C42040170Q24630298-55831C0F-3D0F-4E01-A53F-3606E7512A3DQ26745881-4CFEDAD2-56C9-400E-958D-92DAB2264C17Q26765411-336F334B-C69B-4B70-A0E1-591C7FF22F5FQ26771646-8D504BD1-8C20-4404-A9B5-3D5262220D08Q26829782-3FF3DC1C-C293-4A17-9D54-6385A2E77C52Q27022485-E824B536-40F0-41A2-BC8A-AA7F28465A44Q28081264-7058A3C2-7A09-42C4-9610-E0A3999F860DQ28506459-8FF6F23C-7422-4D9B-B3C6-5D4EC970826BQ28507015-E1AE7AAD-3058-4CDC-85AC-8D265B6B2382Q28507332-D8057432-91BC-44D4-8D7C-1E4D9DF86A8CQ28507588-8508A43B-52AE-4102-B6AF-B957548CB644Q28509809-DE3A0536-5FF9-4766-9E9A-6586890E8389Q28587525-A11AC74C-CAD7-42C7-820C-2862DE9D98C7Q28588538-51065996-80D4-42F0-B84A-C9D5DA93A175Q28593881-043852DE-16E8-4BCA-8942-DA2F7AA9C85FQ30492569-6C4405BB-0E5D-4EC5-B4F3-D3D86AB6A8E7Q33547282-FBF7DE70-7137-4C9E-8F09-A98A6E0788F3Q33702044-67C3FB24-8E10-4941-B971-103505FDD8C6Q33730198-00C0C828-4E52-448F-AEBD-3BA7CDE35B24Q33757724-330AC0B6-113B-43F9-B23D-05ED4C38D682Q33771760-1EEEA84B-EBF5-4FF8-850C-876CDB9E8158Q33815664-1D16F7CE-E03F-467A-BBE7-4BC290B6BB63Q34031587-E59413A3-E25F-4008-8762-C2C515AD2128Q34130078-19DF71A4-8E90-4F9E-82A4-E39FAAEB6FD1Q34160562-A6DF36DB-3A33-411B-ADD4-094C63E9B734Q34221962-9AD31857-3579-4F04-BCAD-6561C89EFC39Q34263325-2EADDB4E-2746-4253-9375-474A10B2CCBCQ34319004-8CAA8348-3278-4604-9341-F6E23DF66F90Q34332458-661B3484-E3F5-4095-B4F2-6F2E1992467BQ34409239-DC8B6074-C437-481A-ADE7-108A39151BFCQ34519292-9336D550-1870-4DD0-AD37-8BAAB815F05DQ34526951-65009EE8-BDE2-47BD-A50C-48B7CC055509Q34543713-2CBC110E-98B0-4F78-BFF5-EA10D78B508FQ34576254-AD06E68D-9B0B-43B9-B40E-DB1CDBB9DD36Q34577722-2410BC58-E533-46EF-972C-0C17089B4E05Q34597786-222D5302-88CC-4A13-9607-D7E9B26BE707Q34611802-A2DCF1F5-E601-45B8-AEDC-F9EFBC3137EA
P2860
Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@ast
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@en
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@nl
type
label
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@ast
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@en
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@nl
prefLabel
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@ast
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@en
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@nl
P2093
P2860
P50
P356
P1433
P1476
Neurogenin3 is differentially ...... stinal and gastric epithelium.
@en
P2093
Céline Uhl
Francois Guillemot
Marjorie Jenny
Michèle Kedinger
Valérie Guillermin
P2860
P304
P356
10.1093/EMBOJ/CDF649
P407
P577
2002-12-01T00:00:00Z